Cogent Biosciences News

Cogent Biosciences | ARS: Annual Report to Security Holders

16:41 ET

Cogent Biosciences | DEFA14A: Others

16:38 ET

Cogent Biosciences | DEF 14A: Definitive information statements

16:38 ET

Cogent Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 16:36 ET

Cogent Biosciences | EFFECT: Others

Apr 11 06:04 ET

Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ferrante Karen Jean

Apr 2 18:25 ET

Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%), etc.

Apr 1 18:33 ET

Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC

Apr 1 18:23 ET

Cogent Biosciences | S-3: Registration statement for specified transactions by certain issuers

Mar 29 16:14 ET

Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%), etc.

Mar 27 16:41 ET

Cogent Biosciences | 8-K: Current report

Mar 22 08:36 ET

Cogent Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 26 16:37 ET

Cogent Biosciences | 10-K: Annual report

Feb 26 09:15 ET

Cogent Biosciences | 8-K: Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Feb 26 08:35 ET

Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(18.89%),Fairmount Healthcare Fund II GP LLC(15.99%), etc.

Feb 16 18:57 ET

Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Fairmount Funds Management LLC

Feb 16 18:47 ET

Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%), etc.

Feb 14 20:38 ET

Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(7.1%),Commodore Capital Master LP(7.1%)

Feb 14 18:08 ET

Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Feb 14 17:32 ET

Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(6.1%),Point72 Asset Management, L.P.(6.0%), etc.

Feb 14 16:20 ET